RADIOIODINATED IODOBENZOYL CONJUGATES OF A MONOCLONAL-ANTIBODY FAB FRAGMENT - INVIVO COMPARISONS WITH CHLORAMINE-T-LABELED FAB

被引:29
作者
WILBUR, DS [1 ]
HADLEY, SW [1 ]
GRANT, LM [1 ]
HYLARIDES, MD [1 ]
机构
[1] NEORX CORP,SEATTLE,WA 98119
关键词
D O I
10.1021/bc00008a006
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A comparative investigation of the biodistributions of radioiodinated p- and m-iodobenzoyl conjugates of a monoclonal antibody Fab fragment, NR-LU-10 Fab, and the same antibody Fab fragment radioiodinated by the chloramine-T (ChT) method has been carried out in mice. Coinjected, dual-isotope studies in athymic mice with tumor xenografts have demonstrated that there are only minor differences in the in vivo distributions of the iodobenzoyl-labeled Fabs, except in the excretory organs, kidneys, and intestines, where major differences were observed. Similarly, coinjection of either the p-iodobenzoyl or m-iodobenzoyl conjugate of NR-LU-10 Fab with the Fab radioiodinated with ChT/radioiodide into BALB/c mice provided additional data that indicated that the two iodobenzoyl conjugates distributed similar in a number of selected tissues. The tissue-distribution differences of the regioisomeric iodobenzoyl conjugates in relation to the ChT-radioiodinated Fab were large for the stomach and neck, consistent with previous studies. The most notable difference between the two iodobenzoyl conjugates was the kidney activity, where the m-iodobenzoyl conjugate was similar to the directly labeled Fab, but the p-iodobenzoyl-conjugated Fab was higher by nearly a factor of 2.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 33 条
  • [1] AXWORTHY D B, 1989, Journal of Nuclear Medicine, V30, P793
  • [2] BADGER CC, 1990, NUCL MED BIOL, V17, P381
  • [3] CARRASQUILLO JA, 1984, CANCER TREAT REP, V68, P317
  • [4] EARY JF, 1989, ANTIBODIES RADIODIAG, P97
  • [5] THE DEIODINATION OF THE IODOTHYRONINES AND OF THEIR DERIVATIVES IN MAN
    ENGLER, D
    BURGER, AG
    [J]. ENDOCRINE REVIEWS, 1984, 5 (02) : 151 - 184
  • [6] GARG P K, 1988, Journal of Nuclear Medicine, V29, P834
  • [7] GARG PK, 1990, CANCER RES, V50, P3514
  • [8] LABELING PROTEINS USING ARYL IODIDE ACYLATION AGENTS - INFLUENCE OF META VS PARA SUBSTITUTION ON INVIVO STABILITY
    GARG, PK
    SLADE, SK
    HARRISON, CL
    ZALUTSKY, MR
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1989, 16 (07): : 669 - 673
  • [9] GOLDENBERG DM, 1990, CANCER RES, V50, pS909
  • [10] HADLEY S W, 1989, Journal of Nuclear Medicine, V30, P924